Avolosin® is combination of two medicine, dutasteride and tamsulosin hydrochloride, the tamsulosin belongs to the alpha- blockers group and dutasteride belongs to the 5-reductase enzyme inhibitors groups. This medicine use to the management of moderate to severe of BPH, reduction in risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.
Effect of Avolosin® on BPH:
| Effect on BPH | Tamsulosin (α-blocker) | dutasteride (5-ARI) |
| Improve symptoms/flow | Yes | Yes |
| Rapid onset of symptom relief(1-2 weeks) | Yes | No |
| Sustained symptomatic benefit | No | Yes |
| Reduce Prostate Volume (PV) | No | Yes |
| Maintain reductions in PV | No | Yes |
| Reduce longer- term risk of AUR and need for BPH surgery | No | Yes |
Usage: The recommended dose is one capsule taken once a day, 30 minutes after the same meal each day.
Ingredient: 0.4mg Tamsulosin Hydrochloride + 0.5mg Dutasteride
Dosage form: Capsule
Packaging: 30 Capsules in a bottle and box with leaflet.
Catalog:
Tap the button to view the product catalog.
